Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Docebo Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 6-K Quarterly results
Docs: "6-K",
"UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL",
"MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023",
"Docebo Reports Second Quarter 2023 Results",
"FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE",
"FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE"
07/17/2023 6-K Quarterly results
05/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Announces Normal Course Issuer Bid TORONTO, ONTARIO - May 15, 2023: Docebo Inc. , a leading learning platform provider with AI capabilities, announced today that the Toronto Stock Exchange has approved its notice of intention to make a normal course issuer bid for a portion of its common shares . Docebo's normal course issuer bid will be made in accordance with the requirements of the Toronto Stock Exchange. Pursuant to the notice, Docebo is authorized to acquire up to a maximum of 1,650,672 of its Shares, or approximately 5% of total shares outstanding as of May 1, 2023, for cancellation over the next 12 months. Purchases under the NCIB will be made through the facilities of the Toronto Stock Exchange, other designated exchanges and or Canadian alternative trading systems and in accordanc..."
05/11/2023 6-K Quarterly results
Docs: "6-K",
"UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL",
"MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2023",
"Docebo Reports First Quarter 2023 Results",
"FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE",
"FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE"
05/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Docebo Inc. Notice of Annual Meeting of Shareholders and Management Information Circular",
"Docebo Inc. Notice and Access Notification",
"Docebo Inc. Form of Proxy",
"Docebo Inc. Voting Instruction Form",
"Docebo Inc. Notice of Annual Meeting of Shareholders and Management Information Circular"
03/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Docebo Reports Fourth Quarter and Fiscal Year 2022 Results"
08/11/2022 6-K Quarterly results
Docs: "6-K",
"UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL",
"MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022",
"Docebo Reports Second Quarter 2022 Results Consistent Execution and Revenue Growth Drive Positive Free Cash Flow",
"Exhibit 99.4 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE",
"Exhibit 99.5 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE"
06/17/2022 6-K Quarterly results
05/12/2022 6-K Quarterly results
03/10/2022 6-K Quarterly results
03/09/2022 6-K Quarterly results
01/24/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Docebo Expands APAC Presence With Acquisition of Skillslive"
01/04/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Docebo Announces Filing of Prospectus for Selling Shareholder At-The-Market Offering Program TORONTO, ON, JANUARY 4, 2022 /CNW/ - Docebo Inc. , a leading artificial intelligence -powered learning suite provider, today announced a new at-the-market equity offering program that allows Intercap Equity Inc. to sell up to US$200.0 million of existing common shares of the Company to the public, from time to time, at Intercap's discretion. The Company will not make any sales under the ATM Program and will not receive any proceeds from the ATM Program. No sales will be made through a stock exchange or stock market in Canada. Sales under the ATM Program are not expected to begin at least until after the issuance of the Company's 2021 financial results in March 2022. All sales under the ATM Program ..."
11/12/2021 6-K Quarterly results
Docs: "6-K",
"Unaudited Condensed Consolidated Interim Financial Statements of the Registrant for the nine months ended September 30, 2021",
"Management’s Discussion and Analysis of Financial Condition and Results of Operations of the Registrant for the three and nine months ended September 30, 2021",
"Docebo Reports Third Quarter 2021 Results Record Net Annual Recurring Revenue additions driven by record new logo and average contract value growth",
"Docebo Inc. – Form 52-109F2 Certificate of Interim Filings by CEO (pursuant to Canadian regulations)",
"Docebo Inc. – Form 52-109F2 Certificate of Interim Filings by CFO (pursuant to Canadian regulations)"
09/23/2021 6-K Quarterly results
09/20/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Docebo Inc. Underwriting Agreement",
"Consent of Goodmans LLP",
"Consent of Stikeman Elliott",
"Consent of PricewaterhouseCoopers",
"Side Letter to the Investor Rights Agreement"
09/17/2021 6-K Quarterly results
09/13/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Docebo Inc. Announces Chief Financial Officer Transition"
08/12/2021 6-K Quarterly results
08/03/2021 6-K Quarterly results
08/03/2021 6-K Quarterly results
06/17/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Docebo Inc. Report of Voting Results",
"Docebo Inc. Report of Voting Results",
"Docebo Inc. Announces Voting Results from its Annual General Meeting of Shareholders"
05/18/2021 6-K Quarterly results
05/13/2021 6-K Quarterly results
05/05/2021 6-K Quarterly results
04/13/2021 6-K Quarterly results
04/05/2021 6-K Quarterly results
03/11/2021 6-K Quarterly results
02/22/2021 6-K Quarterly results
01/26/2021 6-K Quarterly results
01/22/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Underwriting Agreement",
"Consent of Goodmans LLP",
"Consent of Stikeman Elliott LLP",
"Docebo Announces Pricing of Secondary Public Offering in the United States and Canada TORONTO——Docebo Inc. today announced the pricing of its previously announced marketed secondary public offering of common shares in the United States and Canada. The offering is comprised of 2,013,288 common shares offered by certain of Docebo's shareholders, namely Intercap Equity Inc. , Claudio Erba and Alessio Artuffo , at a price to the public of US$49.67 per share for aggregate gross proceeds of US$100 million. 1,811,960 common shares are being offered by Intercap, 150,996 common shares are being offered by Erba and 50,332 common shares are being offered by Artuffo. The offering is expected to close on January 26, 2021, subject to customary closing conditions. The offering is being conducted through..."
01/20/2021 6-K Quarterly results
12/07/2020 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Docebo Announces Closing of Initial Public Offering in the United States and Public Offering in Canada TORONTO—December 7, 2020——Docebo Inc. today announced the closing of its previously-announced marketed public offering of common shares in the United States and Canada. A total of 3,450,000 common shares of Docebo were sold, including 450,000 common shares following the exercise in full by the underwriters of their over-allotment option, at a price of US$48.00 per share, for gross proceeds to the Company of US$165.6 million. Docebo expects that the net proceeds of the offering will be used primarily to strengthen the Company's financial position and allow it to pursue its growth strategies, which include: expanding its customer base; supporting the growth of existing customers; expanding..."
12/03/2020 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Underwriting Agreement",
"Docebo Announces Pricing of Upsized Initial Public Offering in the United States and Public Offering in Canada TORONTO—December 2, 2020—— Docebo Inc. today announced the pricing of its previously announced marketed public offering of 3,000,000 common shares at a price to the public of US$48.00 per share in the United States and Canada, for aggregate gross proceeds to Docebo of US$144,000,000. The size of the offering has been increased from the previously announced US$125,000,000. The common shares of Docebo are expected to begin trading on The Nasdaq Global Select Market under the symbol “DCBO” on December 3, 2020, and will continue to trade on the Toronto Stock Exchange under the symbol “DCBO”. The offering is expected to close on December 7, 2020, subject to customary closing condition...",
"Underwriting Agreement"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy